期刊文献+

溶脲脲原体在抗生素临界浓度下药物敏感性研究

Study on Antibiotic Susceptibility of Ureaplasma Urealyticum in the Concentration of MIC Breakpoints for Highly Sensitivity
下载PDF
导出
摘要 目的 :为了研究溶脲脲原体 (UU)在抗生素临界浓度下的药物敏感性情况。方法 :在 UU最小抑菌浓度 (MIC)的质控范围内 ,选择临床上常用抗生素的高度敏感临界值作为 UU培养基的最终浓度 ,通过代谢抑制法 ,观察 6株临床耐药菌株在这些抗生素临界浓度下生长的情况。结果 :在 4.0μg/ m L的四环素族浓度、0 .5μg/ m L的大环内酯类浓度、2 .0μg/ m L氧氟沙星浓度和 1 .0μg/ m L环丙沙星浓度下 ,这些菌株所显示的体外药物敏感性与临床实际回顾性分析的结果有较好的吻合性。结论 :确立 UU的抗生素高度敏感临界值将有助于简化临床上 Objective: To study the antibiotic susceptibility of ureaplasma urealyticum in the concentration of MIC breakpoints for highly sensitivity. Methods: According to the determining MIC range of antibiotics against ureaplasma urealyticum (UU), MICs breakpoint for highly susceptibility was chosen as the final antibiotic concentration in the broth of UU in order to observe the growth of six isolated UU resistant strains. After the incubation with antibiotics for 12 h, sensitivity was judged empirically depending on the pH indicator. Results: The antimicrobiol susceptibility of these screened strains in vitro was well consistent with the retrospective analysis clinically, which supported the hypothesis that ≤ 4.0 μg/mL for tetracycline group, ≤ 0.5 μg/mL for macrolides, ≤2.0 μg/mL for ciprofloxacin and ≤1.0 μg/mL for ofloxacin were considered highly sensitive to UU in vitro. Conclusion: The result will be applied to commercial kits which may simplify the procedure of testing the susceptibility of UU.
出处 《生殖与避孕》 CAS CSCD 北大核心 2002年第2期117-119,共3页 Reproduction and Contraception
基金 中华医学会皮肤科学会科研基金资助
关键词 溶脲脲原体 药物敏感性 抗生素临界浓度 ureaplasma urealyticum(UU), antibiotic susceptibility, breakpoint for highly susceptibility
  • 相关文献

参考文献6

  • 1Waites KB, Sims PJ, Crouse DT, Geerts MH, Shoup RE, Hamrick WB, Duffy LB & Cassell GH. Serum concentrations of erythromycin after intravenous infusion in preterm neonates treated for Ureaplasma urealyticum infection. Pediatr Infect Dis J, 1994,13:287
  • 2Waites KB, Crouse DT & Cassell GH. Antibiotic susceptibilities and therapeutic options for Ureaplasma urealyticum infections in neonates. Pediatr Infect Dis J,1992,11:23
  • 3National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing: Third Information. Supplement. NCCLs Document M100-S3. Villanova, PA: National Committee for Clinical Laboratory Standards. 1991
  • 4Bébéar C, Robertson JA. Molecular and diagnostic procedures in mycoplasmology. Vol. Ⅱ. Academic Press Inc. 1996, p. 189
  • 5Renaudin R, Bébéar C & Robertson JA. In vitro susceptibility of tetracycline-resistant strains of Ureaplasma urealyticum to newer macrolides and quinolones,and a streptogramin. European Journal of Clinical Microbiology & Infectious Diseases, 1991,10 : 984
  • 6Roberts MC & Kenny GE. TetM tetracycline-resistant determinants in Ureaplasma urealyticum. Pediatr Infect Dis, 1986, 5:s338

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部